Dr. Michael Choi, MD
Pathology (Anatomic Pathology & Clinical Pathology Physician)
- Medicare participating
At a glance
- Years since graduation
- 19
- In the NPI registry since
- 2007
- Medicare patients seen, 2024
- 737
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 2007Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Anatomic Pathology & Clinical Pathology Physician primary
OH license 35.097026 -
Cytopathology Physician
WI license 57375-20
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Morton Plant Hospital Clearwater, FL
- Mease Countryside Hospital Safety Harbor, FL
- Mease Dunedin Hospital Dunedin, FL
- Morton Plant North Bay Hospital New Port Richey, FL
Medical groups
- Clearwater PAthology Associates (11 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 737
- Services billed
- 2,856
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Pathology examination of tissue using a microscope, intermediate complexity | 770 | 211 |
| Special stained specimen slides to examine tissue, each additional procedure | 143 | 38 |
| Special stained specimen slides to examine tissue, initial procedure | 96 | 57 |
| Pathology examination of tissue using a microscope, moderately low complexity | 40 | 37 |
| Pathology examination of tissue using a microscope, moderately high complexity | 40 | 19 |
| Cell examination of specimen, selective cellular enhancement technique | 23 | 18 |
| Preparation of tissue for examination by removing any calcium present | 18 | 12 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Payments from drug and device companies
In 2025, 3 companies reported 20 payments worth $998 in total to this clinician.
| Teleflex LLC | $470 |
|---|---|
| Neurocrine Biosciences, Inc. | $452 |
| Lundbeck LLC | $75.92 |
| Food and Beverage | $585 |
|---|---|
| Travel and Lodging | $413 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Teleflex LLC Apr 28, 2025 | Travel and Lodging TITAN SGS BAILOUT CHUCK · SURGICAL · travel to ATLANTA, GA · in-kind | $413 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.